These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 16416007)

  • 1. Silencing of DMBT1 in neuroblastoma cell lines is not due to methylation of CCWGG motifs on its promoter.
    Muñoz J; Castresana JS
    Neoplasma; 2006; 53(1):15-8. PubMed ID: 16416007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of DMBT1 gene expression in human oral squamous cell carcinoma.
    Imai MA; Moriya T; Imai FL; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Tanzawa H
    Int J Mol Med; 2005 Apr; 15(4):585-9. PubMed ID: 15754018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients.
    Agirre X; Vizmanos JL; Calasanz MJ; García-Delgado M; Larráyoz MJ; Novo FJ
    Oncogene; 2003 Feb; 22(7):1070-2. PubMed ID: 12592393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification.
    Misawa A; Inoue J; Sugino Y; Hosoi H; Sugimoto T; Hosoda F; Ohki M; Imoto I; Inazawa J
    Cancer Res; 2005 Nov; 65(22):10233-42. PubMed ID: 16288011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous deletion and expression of PTEN and DMBT1 in human primary neuroblastoma and cell lines.
    Muñoz J; Lázcoz P; Inda MM; Nistal M; Pestaña A; Encío IJ; Castresana JS
    Int J Cancer; 2004 May; 109(5):673-9. PubMed ID: 14999773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 promoter methylation in human gliomas.
    Amatya VJ; Naumann U; Weller M; Ohgaki H
    Acta Neuropathol; 2005 Aug; 110(2):178-84. PubMed ID: 16025287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines.
    Doerr JR; Malone CS; Fike FM; Gordon MS; Soghomonian SV; Thomas RK; Tao Q; Murray PG; Diehl V; Teitell MA; Wall R
    J Mol Biol; 2005 Jul; 350(4):631-40. PubMed ID: 15967459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.
    Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H
    Oncol Rep; 2006 May; 15(5):1281-5. PubMed ID: 16596198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genomic structure of the DMBT1 gene: evidence for a region with susceptibility to genomic instability.
    Mollenhauer J; Holmskov U; Wiemann S; Krebs I; Herbertz S; Madsen J; Kioschis P; Coy JF; Poustka A
    Oncogene; 1999 Nov; 18(46):6233-40. PubMed ID: 10597221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity.
    Guarcello V; Blanquicett C; Naguib FN; El Kouni MH
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):85-96. PubMed ID: 17805539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative and positive effects of an IAP-LTR on nearby Pcdaalpha gene expression in the central nervous system and neuroblastoma cell lines.
    Sugino H; Toyama T; Taguchi Y; Esumi S; Miyazaki M; Yagi T
    Gene; 2004 Aug; 337():91-103. PubMed ID: 15276205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
    Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
    Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
    Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.
    Wang Y; Li J; Cui Y; Li T; Ng KM; Geng H; Li H; Shu XS; Li H; Liu W; Luo B; Zhang Q; Mok TS; Zheng W; Qiu X; Srivastava G; Yu J; Sung JJ; Chan AT; Ma D; Tao Q; Han W
    Cancer Res; 2009 Jun; 69(12):5194-201. PubMed ID: 19509237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Larger numbers of silenced genes in cancer cell lines with increased de novo methylation of scattered CpG sites.
    Moriguchi K; Yamashita S; Tsujino Y; Tatematsu M; Ushijima T
    Cancer Lett; 2007 May; 249(2):178-87. PubMed ID: 16971039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lineage-specific silencing of human IL-10 gene expression by promoter methylation in cervical cancer cells.
    Szalmás A; Bánáti F; Koroknai A; László B; Fehér E; Salamon D; Gergely L; Minárovits J; Kónya J
    Eur J Cancer; 2008 May; 44(7):1030-8. PubMed ID: 18378443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.